These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Therapeutic drug monitoring. Pharmacokinetics. Taylor WJ Am J Med Technol; 1983 Aug; 49(8):557-63. PubMed ID: 6670671 [No Abstract] [Full Text] [Related]
24. Mutagenic, teratogenic and pharmacokinetic properties of cyclophosphamide and some of its deuterated derivatives. Nau H; Spielmann H; Lo Turco Mortler CM; Winckler K; Riedel L; Obe G Mutat Res; 1982 Aug; 95(2-3):105-18. PubMed ID: 6750378 [TBL] [Abstract][Full Text] [Related]
26. Clinical pharmacology: drug absorption. Scott AK; Hawksworth GM Br Med J (Clin Res Ed); 1981 Feb; 282(6262):462-3. PubMed ID: 6780074 [No Abstract] [Full Text] [Related]
27. Ethylene dichloride: a review of its metabolism, mutagenic and carcinogenic potential. Davidson IW; Sumner DD; Parker JC Drug Chem Toxicol; 1982; 5(4):319-88. PubMed ID: 6762961 [No Abstract] [Full Text] [Related]
28. Application of pharmacokinetics in drug safety evaluation. Singhvi SM; Keim GR; Migdalof BH Regul Toxicol Pharmacol; 1985 Mar; 5(1):3-17. PubMed ID: 3991931 [TBL] [Abstract][Full Text] [Related]
29. A timeline of stable isotopes and mass spectrometry in the life sciences. Lehmann WD Mass Spectrom Rev; 2017 Jan; 36(1):58-85. PubMed ID: 26919394 [TBL] [Abstract][Full Text] [Related]
30. [Drugs and the organism--introduction to pharmacokinetics and biotransformation]. Pfeifer S; Borchert HH Pharmazie; 1978; 33(2-3):128-74. PubMed ID: 674304 [No Abstract] [Full Text] [Related]
31. Isotope effects: definitions and consequences for pharmacologic studies. Van Langenhove A J Clin Pharmacol; 1986; 26(6):383-9. PubMed ID: 3734126 [TBL] [Abstract][Full Text] [Related]
32. Biotransformation and excretion: metabolite identification: other mass spectrometric methods. Perchalski RJ; Lee MS; Yost RA J Clin Pharmacol; 1986; 26(6):435-42. PubMed ID: 3734133 [No Abstract] [Full Text] [Related]
33. [Pharmacokinetic mechanisms of drug interactions]. Kvĕtina J; Fendrich Z Cas Lek Cesk; 1978 Apr; 117(17):521-3. PubMed ID: 657222 [No Abstract] [Full Text] [Related]
34. Interrelationship between renal haemodynamics, drug kinetics and drug action. Duchin KL; Schrier RW Clin Pharmacokinet; 1978; 3(1):58-71. PubMed ID: 346284 [No Abstract] [Full Text] [Related]
36. Bioavailability and pharmacokinetic analysis of drug responding systems. Smolen VF Annu Rev Pharmacol Toxicol; 1978; 18():495-522. PubMed ID: 348066 [No Abstract] [Full Text] [Related]
37. [The effect of interactions on absorption, distribution and excretion of drugs]. Dettli L Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1567-74. PubMed ID: 611881 [No Abstract] [Full Text] [Related]
38. Embryotoxicity of stable isotopes and use of stable isotopes in studies of teratogenetic mechanisms. Spielmann H; Nau H J Clin Pharmacol; 1986; 26(6):474-80. PubMed ID: 3734139 [TBL] [Abstract][Full Text] [Related]
39. [Species differences in pharmaco-kinetics of chemicals. Correlations with toxicity (author's transl)]. Keck G Toxicol Eur Res; 1981 Jul; 3(4):207-15. PubMed ID: 7302948 [TBL] [Abstract][Full Text] [Related]
40. Acute and chronic toxicity of caffeine: a review. Dalvi RR Vet Hum Toxicol; 1986 Apr; 28(2):144-50. PubMed ID: 2871652 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]